Skip to main content
New — The Peptide Dictionary: 128 terms, explained simply
New guide — NAD+ for Anti-Aging: What the Science Says
New guide — GHK-Cu: the copper peptide for your skin
Not sure where to start? — A 60-second quiz points you to the path that fits your goal
New explainer — Semaglutide: what the research says, made simple
Browse — Peptide guides, made simple
New — The Peptide Dictionary: 128 terms, explained simply
New guide — NAD+ for Anti-Aging: What the Science Says
New guide — GHK-Cu: the copper peptide for your skin
Not sure where to start? — A 60-second quiz points you to the path that fits your goal
New explainer — Semaglutide: what the research says, made simple
Browse — Peptide guides, made simple
Easy-to-follow guides
Independent reviews
Vetted providers
Free to read

Home / Peptide legality / New Hampshire

Peptide legality · New Hampshire · updated 2026-09-21

Are peptides legal in New Hampshire?

Gray area

Peptide therapy is legal in New Hampshire when it involves an FDA-approved medicine prescribed by a licensed clinician, while research peptides such as BPC-157 and TB-500 remain in a federal gray zone that New Hampshire has not separately banned.

Legal status overview

Peptide therapy is legal in New Hampshire when it involves an FDA-approved medicine prescribed by a licensed clinician, while research peptides such as BPC-157 and TB-500 remain in a federal gray zone the state has not separately banned. Compounding is governed by RSA 318:14-a and the New Hampshire Board of Pharmacy within the federal 503A framework. Approved peptide medicines such as Wegovy® (semaglutide) are available with a valid prescription, while non-approved compounded peptides cannot be lawfully compounded today. This is general information, not legal or medical advice.

Key points

  • FDA-approved peptide medicines, including Wegovy® (semaglutide) and Ozempic® (semaglutide), remain legal in New Hampshire with a valid prescription. [7]
  • New Hampshire has not enacted a peptide-specific ban; compounding is governed by RSA 318:14-a and the New Hampshire Board of Pharmacy within the federal 503A framework. [1]
  • State law lets a pharmacist compound a limited quantity from the active ingredient during a commercial shortage for a patient with a valid prescription; because approved GLP-1 medicines are no longer in shortage, that exception no longer covers them. [1]
  • Effective December 26, 2024, the New Hampshire Board of Pharmacy approved a standing order on compounding certain parenteral drug products. [2]
  • BPC-157 is not FDA-approved; not a generic; not evaluated by the FDA, and cannot be lawfully compounded under Section 503A. It was removed from FDA Category 2 on April 15, 2026 but not cleared for compounding. [3]
  • TB-500 (thymosin beta-4) is not FDA-approved and is treated by the FDA as a bulk substance with safety concerns, so it cannot be lawfully compounded. [4]
  • Growth hormone (somatropin) is prescription-only and not a controlled substance, but federal law makes distribution for non-medical uses such as bodybuilding a felony. [5]
  • States can restrict peptide practice above the federal floor even when the source pharmacy is legitimate, so New Hampshire providers should reverify status at each FDA update. [6]

Compound-by-compound status

BPC-157
Restricted
Not FDA-approved; not a generic; not evaluated by the FDA. Cannot be lawfully compounded under Section 503A. Removed from FDA Category 2 on April 15, 2026 but not moved to Category 1.
GLP-1 class (semaglutide, tirzepatide)
Legal
Approved brands such as Wegovy® (semaglutide) and Zepbound® (tirzepatide) are legal with a prescription. Compounded versions are not FDA-approved; not a generic; not evaluated by the FDA, and are no longer covered by the shortage exception.
TB-500 (thymosin beta-4)
Restricted
Not FDA-approved; not a generic; not evaluated by the FDA. Classed by the FDA as a bulk substance with safety concerns and not eligible for 503A compounding.
Growth hormone (somatropin)
Legal
Prescription-only and not a controlled substance. FDA-approved for defined medical indications; federal law criminalizes distribution for non-medical uses.

Frequently asked questions

Are peptides legal in New Hampshire?

FDA-approved peptide medicines are legal in New Hampshire with a valid prescription. Non-approved research peptides such as BPC-157 and TB-500 are not FDA-approved and cannot be lawfully compounded, so they occupy a gray zone. This is general information, not advice.

Can a New Hampshire pharmacy compound BPC-157?

No. BPC-157 is not FDA-approved and cannot be lawfully compounded under Section 503A. Its April 15, 2026 removal from FDA Category 2 did not clear it for compounding.

Is compounded semaglutide still available in New Hampshire?

The shortage exception that once allowed compounded semaglutide has ended now that the medicine is off the national shortage list. Approved brands such as Wegovy® (semaglutide) remain available by prescription.

Who can prescribe peptide therapy in New Hampshire?

A licensed prescriber, such as a physician or a nurse practitioner with full practice authority, may evaluate a patient and prescribe an appropriate FDA-approved peptide medicine.

Is growth hormone legal in New Hampshire?

Somatropin is prescription-only and not a controlled substance, but federal law makes distribution for non-medical purposes a felony. A licensed clinician must prescribe it for an approved indication.

General information based on the sourced research above, not legal advice. For a specific situation in New Hampshire, consult a licensed attorney familiar with pharmaceutical law.